![Charles Swanton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 79 055 $ al 31/05/2026
Charles Swanton is the founder of Achilles Therapeutics Plc, founded in 2020, with no titles listed.
Dr. Swanton is the founder of Achilles Therapeutics UK Ltd., founded in 2016, with no titles listed.
Dr. Swanton is the founder of The Francis Crick Institute Ltd., founded in 2016, holding the title of Deputy Director-Clinical since 2023.
Dr. Swanton is also the founder of University College London.
Current jobs include Director at American Association for Cancer Research since 2019, Director at Bicycle Therapeutics Plc since 2025, and Director at Novartis AG starting in 2026.
Former jobs include Co-Director-Lung Cancer Centre of Excellence at Cancer Research UK and a position at UCL Medical School.
Education includes undergraduate studies at UCL Medical School and both undergraduate and doctorate degrees from University College London.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 13/04/2026 | 16.856 ( 0,04 % ) | 79 055 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Director/Miembro de la Junta | 12/08/2025 |
| NOVARTIS AG | Director/Miembro de la Junta | 06/03/2026 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Director/Miembro de la Junta | 01/01/2019 |
The Francis Crick Institute Ltd.
 The Francis Crick Institute Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates as an independent charity that engages in biomedicine research | Fundador | - |
| Empresas | Cargo | Fin |
|---|---|---|
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Fundador | 01/01/2025 |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Fundador | - |
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Provides cancer research services | Corporate Officer/Principal | - |
| ACHILLES THERAPEUTICS PLC | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cancer Research UK
Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Provides cancer research services | Commercial Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
Bicycle Therapeutics Plc
 Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
The Francis Crick Institute Ltd.
The Francis Crick Institute Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates as an independent charity that engages in biomedicine research | Miscellaneous |
UCL Medical School
 UCL Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Achilles Therapeutics Plc
 Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
